Supreme Pharmaceuticals Outlines 2015 Plans

Supreme Pharmaceuticals Inc. (TSXV:SL,CSE:SL) released a letter from President John Fowler. It looks at what the company accomplished in 2014, also touching briefly on 2015 plans.

As quoted in the press release:

In December 2014 we were thrilled to announce the completion of our $4,000,000 pre-license construction project at the Kincardine facility. With the completion of this project, we are now ready and waiting for our Health Canada inspection, which we expect to be successful and complete in the coming weeks. Following a successful inspection, we will begin cultivation using over 40,000 square feet of the facility which will provide initial revenue capacity of over $6,000,000 per year. But we won’t stop there – by late 2015 we aim to bring on-line an additional 65,000 square feet to grow our revenue capacity to over $12,000,000 per annum. Currently, we are working on a number of distribution options, both in the retail and wholesale markets. In the retail market we believe our greenhouse grown medical marijuana will be among the most affordable in the marketplace, which should encourage new patient acquisition and also repeat and consistent orders from existing patients. In addition we are looking to partner with multiple patient acquisition firms and pharmaceutical marketing entities to drive patient acquisition and encourage doctors to suggest our affordable medical marijuana over other options in the marketplace.

Click here to read the full Supreme Pharmaceuticals Inc. (TSXV:SL,CSE:SL) press release.